A study has revealed that NCBP2-AS2 was overexpressed in hypoxic-cancer-associated fibroblasts, and it can promote the secretion of pro-angiogenic factor VEGFA, consequently reducing VEGF/VEGFR downstream signaling, which leads to tumor metastasis and reduces the efficacy of therapy [39]. This evidence concerns the gene VEGFA and cancer.